Individual investors who have a significant stake must be disappointed along with institutions after Ryman Healthcare Limited's (NZSE:RYM) market cap dropped by NZ$158m

Individual investors who have a significant stake must be disappointed along with institutions after Ryman Healthcare Limited's (NZSE:RYM) market cap dropped by NZ$158m

Key Insights

  • Ryman Healthcare's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public

  • 40% of the business is held by the top 25 shareholders

  • Insiders have been buying lately

To get a sense of who is truly in control of Ryman Healthcare Limited (NZSE:RYM), it is important to understand the ownership structure of the business. With 59% stake, individual investors possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

While institutions, who own 37% shares weren’t spared from last week’s NZ$158m market cap drop, individual investors as a group suffered the maximum losses

Let's take a closer look to see what the different types of shareholders can tell us about Ryman Healthcare.

Check out our latest analysis for Ryman Healthcare

ownership-breakdown
NZSE:RYM Ownership Breakdown August 13th 2023

What Does The Institutional Ownership Tell Us About Ryman Healthcare?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

As you can see, institutional investors have a fair amount of stake in Ryman Healthcare. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Ryman Healthcare, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
NZSE:RYM Earnings and Revenue Growth August 13th 2023

Hedge funds don't have many shares in Ryman Healthcare. Karori Capital Limited is currently the largest shareholder, with 7.7% of shares outstanding. Universal-Investment-Luxembourg SA is the second largest shareholder owning 6.3% of common stock, and BlackRock, Inc. holds about 5.6% of the company stock.

On studying our ownership data, we found that 25 of the top shareholders collectively own less than 50% of the share register, implying that no single individual has a majority interest.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.